We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.98B
AUM Growth
+$70.5M
Cap. Flow
-$33M
Cap. Flow %
-1.66%
Top 10 Hldgs %
15.03%
Holding
324
New
29
Increased
50
Reduced
187
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 19.12%
2 Industrials 18.8%
3 Technology 17.6%
4 Consumer Discretionary 14.29%
5 Financials 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTEK icon
1
Tetra Tech
TTEK
$8.42B
$49.3M 2.48%
5,709,090
-1,202,130
-17% -$9.71M
IDTI
2
DELISTED
Integrated Device Technology I
IDTI
$33.2M 1.67%
1,409,038
+104,101
+8% +$2.4M
STMP
3
DELISTED
Stamps.com, Inc.
STMP
$30M 1.51%
261,944
-1,025
-0.4% -$107K
POOL icon
4
Pool Corp
POOL
$6.78B
$27.9M 1.41%
267,500
-7,297
-3% -$720K
SUPN icon
5
Supernus Pharmaceuticals
SUPN
$2.6B
$27.3M 1.38%
1,081,740
+477,498
+79% +$10.7M
CRTO icon
6
Criteo S.A. Ordinary Shares
CRTO
$1.08B
$27.2M 1.37%
661,467
+53,354
+9% +$2.08M
FCN icon
7
FTI Consulting
FCN
$4.49B
$27.2M 1.37%
602,684
-12,729
-2% -$553K
UMBF icon
8
UMB Financial
UMBF
$11.1B
$25.7M 1.3%
333,473
-7,027
-2% -$488K
XXIA
9
DELISTED
Ixia
XXIA
$25.4M 1.28%
1,574,926
-31,566
-2% -$436K
LOCK
10
DELISTED
LifeLock, Inc.
LOCK
$25M 1.26%
1,043,745
-442,216
-30% -$8.99M
BCPC
11
Balchem Corp
BCPC
$5.28B
$24.9M 1.26%
296,815
-6,561
-2% -$518K
SYNH
12
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$23.8M 1.2%
452,715
-9,321
-2% -$451K
AMRI
13
DELISTED
Albany Molecular Research Inc
AMRI
$23.7M 1.19%
1,261,934
-27,687
-2% -$471K
MWA icon
14
Mueller Water Products
MWA
$3.96B
$23.4M 1.18%
1,759,794
-37,050
-2% -$475K
HCSG icon
15
Healthcare Services Group
HCSG
$1.59B
$22.9M 1.15%
584,440
-11,052
-2% -$422K
LCII icon
16
LCI Industries
LCII
$2.49B
$22.9M 1.15%
212,464
-4,803
-2% -$478K
FN icon
17
Fabrinet
FN
$15.9B
$22.1M 1.11%
548,486
+469,836
+597% +$19.6M
TXRH icon
18
Texas Roadhouse
TXRH
$13.6B
$21.8M 1.1%
452,036
-9,730
-2% -$428K
CATY icon
19
Cathay General Bancorp
CATY
$4.21B
$21.7M 1.09%
569,465
-11,304
-2% -$383K
PEGA icon
20
Pegasystems
PEGA
$4.98B
$21.5M 1.09%
1,196,678
-24,920
-2% -$416K
OZK icon
21
Bank OZK
OZK
$5.59B
$21.5M 1.08%
409,116
+48,840
+14% +$2.17M
LGND icon
22
Ligand Pharmaceuticals
LGND
$5.85B
$21.4M 1.08%
337,552
+2,751
+0.8% +$174K
PTC icon
23
PTC
PTC
$15.9B
$21.1M 1.07%
456,989
-9,371
-2% -$438K
OXM icon
24
Oxford Industries
OXM
$574M
$21.1M 1.07%
351,438
+5,678
+2% +$374K
GMED icon
25
Globus Medical
GMED
$10.7B
$21M 1.06%
847,182
-17,537
-2% -$399K

Similar funds

Rice Hall James & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Rice Hall James & Associates held 324 positions worth $1.98B, up 3.7% from $1.91B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q4 2016 filing shows 29 new, 50 increased, 187 reduced and 28 closed positions. Its largest new stake was Interface: 948,022 shares worth $17.6M. The largest sale was Fleetmatics Group PLC, an estimated $21M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q4 2016 buy was Interface: 948,022 shares worth $17.6M.
  • Rice Hall James & Associates added most to Fabrinet in Q4 2016, an estimated $19.6M increase.
  • Rice Hall James & Associates's biggest Q4 2016 reduction was Tetra Tech, cutting an estimated $9.71M.
  • Rice Hall James & Associates fully exited Fleetmatics Group PLC in Q4 2016, selling an estimated $21M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.98B portfolio in Q4 2016.
  • Rice Hall James & Associates opened 29 new positions and closed 28 in Q4 2016.
  • Rice Hall James & Associates's portfolio value rose 3.7% quarter-over-quarter to $1.98B.

Based on Rice Hall James & Associates's 13F filing for Q4 2016, filed 2 Feb 2017.